The ecological success of Burkholderia terrae BS001 and related strains in the mycosphere
PhD ceremony: Mr. R. Nazir, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: The ecological success of Burkholderia terrae BS001 and related strains in the mycosphere
Promotor(s): prof. J.D. van Elsas
Faculty: Mathematics and Natural Sciences
Rashid Nazir investigated the interactions between bacteria and fungi in soil. He found that: The presence of soil fungi exerts a significant effect on the bacterial community in any soil, so this biological factor is a strong determinant of local bacterial communities. Members of the genus Burkholderia outcompete other bacteria and are preferentially selected in the mycosphere. Some Burkholderia species have adapted themselves to a life with soil fungi; one remarkable capacity was the ability to migrate along growing fungal hyphae. Burkholderia terrae BS001 protects its fungal host against living antagonists as well as against fungicides.
Burkholderia terrae BS001 has a prominent effect on the physiology of the soil fungus Lyophyllum sp. strain Karsten, exhibiting different phenotypes. This bacterium induces glycerol release by the fungus and hinders mushroom formation. Burkholderia terrae BS001 contains 11.5 Mb genome that is one of the biggest one reported till now.
The bacterium B. terrae BS001 and counterpart soil fungi, represent valuable future assets for antibiotics, industrial, environmental as well as for basic scientific landmark potential purposes. The results of Nazir may indicate the future directions for betterment of science as well as for applied areas of Organic agriculture, especially in Bio-Control and applied antibiosis.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.
-
02 July 2025
€ 30 million investment for UG spin-off Portal Biotech
Portal Biotech, a pioneer in nanopore-based protein identification and sequencing technology, has raised € 30 million in Series A funding. The funding will support commercial rollout and team growth.